Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1992;23:1566-1572

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gideon, P.
Right arrow Articles by Arlien-Soborg, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gideon, P.
Right arrow Articles by Arlien-Soborg, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ASPARTIC ACID
*CHOLINE BITARTRATE
*CHOLINE CHLORIDE

Stroke, Vol 23, 1566-1572, Copyright © 1992 by American Heart Association


ARTICLES

Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. A proton magnetic resonance spectroscopy study

P Gideon, O Henriksen, B Sperling, P Christiansen, TS Olsen, HS Jorgensen and P Arlien-Soborg
Danish Research Center of Magnetic Resonance, Hvidovre Hospital, Copenhagen, Denmark.

BACKGROUND AND PURPOSE: The early time course after acute stroke of cerebral N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline was studied in vivo by means of localized water- suppressed proton magnetic resonance spectroscopy. METHODS: Eight patients with acute stroke were studied serially in the acute phase, 1 week after, and 2-4 weeks after the onset of clinical symptoms. Ten healthy volunteers served as controls. A stimulated echo (STEAM) sequence was used for measurement of the brain metabolites in a volume of interest located within the infarcted area as visualized by magnetic resonance imaging. For quantification, the unsaturated water signal was used as the internal standard. Regional cerebral blood flow in the infarcted area was measured relative to a symmetrically located unaffected area by means of single-photon emission computed tomographic scanning, using 99mTc-labeled d,l-hexamethylenepropyleneamine oxime as the flow tracer. RESULTS: Relative regional cerebral blood flow was considerably reduced in the infarcted area in the acute phase. After 1 week, hyperemia was seen in all but one patient. The N-acetylaspartate content was significantly reduced, with the loss appearing to occur between 6 and 24 hours after the stroke incident. The reduction in N- acetylaspartate content was greater in the central part than in the peripheral part of the infarcted area. Creatine and phosphocreatine were also reduced in the infarcted area, whereas no significant change was seen in the choline content. CONCLUSIONS: Assuming that N- acetylaspartate content reflects neuronal survival or loss, our results may suggest that treatment procedures with restoration of blood flow to severely ischemic areas should be initiated within the first 6 hours after stroke onset.


This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
A.L. Coon, F. Arias-Mendoza, G.P. Colby, J. Cruz-Lobo, J. Mocco, W.J. Mack, R.J. Komotar, T.R. Brown, and E.S. Connolly Jr.
Correlation of Cerebral Metabolites with Functional Outcome in Experimental Primate Stroke Using in Vivo 1H-Magnetic Resonance Spectroscopy.
AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 1053 - 1058.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
F. Groenendaal, J. v. d. Grond, and L. S. d. Vries
Cerebral Metabolism in Severe Neonatal Hyperbilirubinemia
Pediatrics, July 1, 2004; 114(1): 291 - 294.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D.R. Rutgers, M.J.P. van Osch, L.J. Kappelle, W.P.T.M. Mali, and J. van der Grond
Cerebral Hemodynamics and Metabolism in Patients With Symptomatic Occlusion of the Internal Carotid Artery
Stroke, March 1, 2003; 34(3): 648 - 652.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W.-J. Chu, G. F. Mason, J. W. Pan, H. P. Hetherington, H.-G. Liu, E. C. San Pedro, and J. M. Mountz
Regional Cerebral Blood Flow and Magnetic Resonance Spectroscopic Imaging Findings in Diaschisis From Stroke
Stroke, May 1, 2002; 33(5): 1243 - 1248.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. M. Wild, J. M. Wardlaw, I. Marshall, and C. P. Warlow
N-Acetylaspartate Distribution in Proton Spectroscopic Images of Ischemic Stroke : Relationship to Infarct Appearance on T2-Weighted Magnetic Resonance Imaging
Stroke, December 1, 2000; 31(12): 3008 - 3014.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. W. Parsons, T. Li, P. A. Barber, Q. Yang, D. G. Darby, P. M. Desmond, R. P. Gerraty, B. M. Tress, and S. M. Davis
Combined 1H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome
Neurology, August 22, 2000; 55(4): 498 - 506.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Wyss and R. Kaddurah-Daouk
Creatine and Creatinine Metabolism
Physiol Rev, July 1, 2000; 80(3): 1107 - 1213.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C A Davie, N C Silver, G J Barker, P S Tofts, A J Thompson, W I McDonald, and D H Miller
Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup?
J. Neurol. Neurosurg. Psychiatry, December 1, 1999; 67(6): 710 - 715.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
R. J.T. Corbett, P. D. Purdy, A. R. Laptook, C. Chaney, and D. Garcia
Noninvasive Measurement of Brain Temperatureafter Stroke
AJNR Am. J. Neuroradiol., November 1, 1999; 20(10): 1851 - 1857.
[Abstract] [Full Text]


Home page
StrokeHome page
S. T. Pendlebury, A. M. Blamire, M. A. Lee, P. Styles, and P. M. Matthews
Axonal Injury in the Internal Capsule Correlates With Motor Impairment After Stroke
Stroke, May 1, 1999; 30(5): 956 - 962.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. M. Wardlaw, I. Marshall, J. Wild, M. S. Dennis, J. Cannon, and S. C. Lewis
Studies of Acute Ischemic Stroke With Proton Magnetic Resonance Spectroscopy : Relation Between Time From Onset, Neurological Deficit, Metabolite Abnormalities in the Infarct, Blood Flow, and Clinical Outcome
Stroke, August 1, 1998; 29(8): 1618 - 1624.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
F. Federico, I. L. Simone, V. Lucivero, P. Giannini, G. Laddomada, D. M. Mezzapesa, and C. Tortorella
Prognostic Value of Proton Magnetic Resonance Spectroscopy in Ischemic Stroke
Arch Neurol, April 1, 1998; 55(4): 489 - 494.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C A Davie, G J Barker, A J Thompson, P S Tofts, W I McDonald, and D H Miller
1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, December 1, 1997; 63(6): 736 - 742.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. van der Grond, R. Balm, L.J. Kappelle, B.C. Eikelboom, and W.P.T.M. Mali
Cerebral Metabolism of Patients With Stenosis or Occlusion of the Internal Carotid Artery : A 1H-MR Spectroscopic Imaging Study
Stroke, May 1, 1995; 26(5): 822 - 828.
[Abstract] [Full Text]


Home page
StrokeHome page
G. D. Graham, P. Kalvach, A. M. Blamire, L. M. Brass, P. B. Fayad, and J. W. Prichard
Clinical Correlates of Proton Magnetic Resonance Spectroscopy Findings After Acute Cerebral Infarction
Stroke, February 1, 1995; 26(2): 225 - 229.
[Abstract] [Full Text]